Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Pharm.D., Ohio State University 1986
• 

  Previous Appointments & Affiliations

  • Adjunct Assistant Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Clinical Science Departments 2003 - 2020
• Recognition
• 

  In the News

  • JUN 23, 2016

    News-Medical

    Study helps identify traits that may cause elders to need help with medications

  • JUN 23, 2016

    News-Medical

    Study helps identify traits that may cause elders to need help with medications
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Jamerson, Brenda D., and T Ho Haryadi. “The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?” Medical Hypotheses 144 (November 2020): 109880. https://doi.org/10.1016/j.mehy.2020.109880.
       Full Text
    • Jamerson, Brenda D., T Ho Haryadi, and Arline Bohannon. “Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?” Arch Med Res 51, no. 7 (October 2020): 743–44. https://doi.org/10.1016/j.arcmed.2020.06.006.
       Full Text  Link to Item
    • Jamerson, Brenda D., Gerda G. Fillenbaum, Richard Sloane, and Miriam C. Morey. “A New Method of Identifying Characteristics of Needing Help to Take Medications in an Older Representative Community-Dwelling Population: The Older Adults Medication Assist Scale.” J Am Geriatr Soc 64, no. 6 (June 2016): 1195–1202. https://doi.org/10.1111/jgs.14166.
       Full Text  Link to Item
    • Jamerson, Brenda D., Martha E. Payne, Melanie E. Garrett, Allison E. Ashley-Koch, Marcy C. Speer, and David C. Steffens. “Folate metabolism genes, dietary folate and response to antidepressant medications in late-life depression.” Int J Geriatr Psychiatry 28, no. 9 (September 2013): 925–32. https://doi.org/10.1002/gps.3899.
       Full Text  Link to Item
    • Herring, Charles, Andrew J. Muzyk, Brenda Jamerson, Carolyn F. Pedley, Ellyn Smith, David Price, and Yoronda Jones. “Use of antidepressants for the treatment of psychiatric illnesses.” J Pharm Pract 23, no. 4 (August 2010): 374–75. https://doi.org/10.1177/0897190010366926.
       Full Text  Link to Item
    • Herring, Charles, Andrew J. Muzyk, and Brenda Jamerson. “Treatment of comorbid depression in medical illness.” J Pharm Pract 23, no. 3 (June 2010): 274–76. https://doi.org/10.1177/0897190010366924.
       Full Text  Link to Item
    • Payne, Martha E., Brenda D. Jamerson, Christopher F. Potocky, Allison E. Ashley-Koch, Marcy C. Speer, and David C. Steffens. “Natural food folate and late-life depression.” J Nutr Elder 28, no. 4 (October 2009): 348–58. https://doi.org/10.1080/01639360903417181.
       Full Text  Link to Item
    • Hatsukami, Dorothy K., Stephen Rennard, Manoj K. Patel, Michael Kotlyar, Robert Malcolm, Mitchell A. Nides, Greg Dozier, Matthew P. Bars, and Brenda D. Jamerson. “Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking.” Am J Med 116, no. 3 (February 1, 2004): 151–57. https://doi.org/10.1016/j.amjmed.2003.07.018.
       Full Text  Link to Item
    • Jamerson, Brenda D., K Ranga Rama Krishnan, Jeremy Roberts, Alok Krishen, and Jack G. Modell. “Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.” Psychopharmacol Bull 37, no. 2 (2003): 67–78.
       Link to Item
    • Jain, Adesh K., Roy A. Kaplan, Kishore M. Gadde, Thomas A. Wadden, David B. Allison, Edwin R. Brewer, Robert A. Leadbetter, et al. “Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.” Obes Res 10, no. 10 (October 2002): 1049–56. https://doi.org/10.1038/oby.2002.142.
       Full Text  Link to Item
    • Fleisher, L. A., S. Hogue, M. Colopy, R. S. Twersky, D. S. Warner, B. D. Jamerson, K. J. Tuman, P. S. Glass, and M. F. Roizen. “Does functional ability in the postoperative period differ between remifentanil- and fentanyl-based anesthesia?” J Clin Anesth 13, no. 6 (September 2001): 401–6. https://doi.org/10.1016/s0952-8180(01)00291-4.
       Full Text  Link to Item
    • Twersky, R. S., B. Jamerson, D. S. Warner, L. A. Fleisher, and S. Hogue. “Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients.” J Clin Anesth 13, no. 6 (September 2001): 407–16. https://doi.org/10.1016/s0952-8180(01)00292-6.
       Full Text  Link to Item
    • Joshi, G. P., B. D. Jamerson, M. F. Roizen, L. Fleisher, R. S. Twersky, D. S. Warner, and M. Colopy. “Is there a learning curve associated with the use of remifentanil?” Anesth Analg 91, no. 5 (November 2000): 1049–55. https://doi.org/10.1097/00000539-200011000-00002.
       Full Text  Link to Item
    • Balakrishnan, G., P. Raudzens, S. K. Samra, K. Song, J. A. Boening, V. Bosek, B. D. Jamerson, and D. S. Warner. “A comparison of remifentanil and fentanyl in patients undergoing surgery for intracranial mass lesions.” Anesth Analg 91, no. 1 (July 2000): 163–69. https://doi.org/10.1097/00000539-200007000-00030.
       Full Text  Link to Item
    • Hogue, S. L., P. R. Reese, M. Colopy, L. A. Fleisher, K. J. Tuman, R. S. Twersky, D. S. Warner, and B. Jamerson. “Assessing a tool to measure patient functional ability after outpatient surgery.” Anesth Analg 91, no. 1 (July 2000): 97–106. https://doi.org/10.1097/00000539-200007000-00019.
       Full Text  Link to Item
    • Warner, D. S., B. D. Jamerson, G. Balakrishnan, J. Boening, V. Bosek, P. Raudzens, S. Samra, and K. Song. “Real-world comparison of fentanyl versus remifentanil based anesthesia for craniotomy.” Anesthesiology 89, no. 3A (September 1, 1998): U324–U324.
       Link to Item
    • Class, P. S. A., B. D. Jamerson, M. Colopy, L. A. Fleisher, M. F. Roizen, K. Tuman, R. Twersky, and D. S. Warner. “Is there a difference in adverse events during general anesthesia based on gender, age, or ethnic group.” Anesthesia and Analgesia 86, no. 2S (February 1, 1998): U115–U115.
       Link to Item
    • Warner, D. S., B. D. Jamerson, M. Colopy, L. A. Fleisher, P. S. A. Glass, M. F. Roizen, K. Tuman, and R. Twersky. “Adverse events during general anesthesia with remifentanil: A phase IV comparison trial.” Anesthesia and Analgesia 86, no. 2S (February 1, 1998): U126–U126.
       Link to Item
    • Warner, D. S., B. J. Hindman, M. M. Todd, P. D. Sawin, J. Kirchner, C. L. Roland, and B. D. Jamerson. “Intracranial pressure and hemodynamic effects of remifentanil versus alfentanil in patients undergoing supratentorial craniotomy.” Anesth Analg 83, no. 2 (August 1996): 348–53. https://doi.org/10.1097/00000539-199608000-00025.
       Full Text  Link to Item

  • Conference Papers

    • Stillwell, T., C. Robbins, A. Riley, M. Ahmed, and B. D. Jamerson. “Planning and implementation of a multimodal medication error tracking, reporting and prevention program.” In Pharmacotherapy, 24:1477–1477. PHARMACOTHERAPY PUBLICATIONS INC, 2004.
       Link to Item
    • Jain, A. K., R. A. Kaplan, K. M. Gadde, T. A. Wadden, D. B. Allison, E. R. Brewer, R. A. Leadbetter, R. M. J. Donahue, K. S. Buaron, and B. D. Jamerson. “A study of bupropion SR compared to placebo in obese adults with mild to moderate depressive symptoms.” In Obesity Research, 9:68S-68S. NORTH AMER ASSOC STUDY OBESITY, 2001.
       Link to Item
• Teaching & Mentoring
• 

  Recent Courses

  • SOCIOL 180S: Society, the Self, and the Natural World 2021

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.